Weiya Xia

30.5k total citations · 12 hit papers
114 papers, 18.0k citations indexed

About

Weiya Xia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weiya Xia has authored 114 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 52 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Weiya Xia's work include Cancer-related Molecular Pathways (19 papers), Virus-based gene therapy research (14 papers) and RNA Interference and Gene Delivery (12 papers). Weiya Xia is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), Virus-based gene therapy research (14 papers) and RNA Interference and Gene Delivery (12 papers). Weiya Xia collaborates with scholars based in United States, Taiwan and China. Weiya Xia's co-authors include Mien‐Chie Hung, Binhua P. Zhou, Bill Spohn, Yongkun Wei, Yong Liao, Gabriel N. Hortobágyi, Shiaw‐Yih Lin, Jiong Deng, Yong Wen and Mehmet Gündüz and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Weiya Xia

114 papers receiving 17.8k citations

Hit Papers

Dual regulation of Snail by GSK-3β-mediated phosphorylati... 2000 2026 2008 2017 2004 2001 2001 2017 2001 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiya Xia United States 56 12.4k 8.0k 3.8k 2.4k 1.8k 114 18.0k
Gerhard Christofori Switzerland 71 12.4k 1.0× 7.1k 0.9× 4.5k 1.2× 1.7k 0.7× 1.8k 1.0× 163 19.6k
Shideng Bao United States 46 10.0k 0.8× 6.9k 0.9× 5.0k 1.3× 2.1k 0.9× 1.4k 0.7× 88 17.4k
Mary W. Brooks United States 24 13.1k 1.1× 10.7k 1.3× 4.7k 1.2× 2.4k 1.0× 1.6k 0.8× 28 21.2k
Ruggero De Maria Italy 72 13.1k 1.1× 9.1k 1.1× 6.1k 1.6× 4.0k 1.7× 1.8k 1.0× 257 22.8k
Elisa de Stanchina United States 65 13.8k 1.1× 7.0k 0.9× 4.9k 1.3× 1.8k 0.8× 3.0k 1.6× 226 19.4k
Daniel E. Johnson United States 46 8.4k 0.7× 4.3k 0.5× 2.3k 0.6× 2.2k 0.9× 1.5k 0.8× 133 13.6k
Varda Rotter Israel 77 11.9k 1.0× 10.2k 1.3× 4.1k 1.1× 1.4k 0.6× 1.2k 0.7× 270 18.4k
Klas G. Wiman Sweden 67 9.3k 0.7× 7.0k 0.9× 2.3k 0.6× 2.0k 0.8× 961 0.5× 179 14.1k
Keping Xie United States 71 11.0k 0.9× 5.5k 0.7× 5.4k 1.4× 2.0k 0.8× 1.4k 0.7× 210 17.2k
Giorgio Stassi Italy 62 9.1k 0.7× 9.0k 1.1× 4.3k 1.1× 3.9k 1.6× 1.1k 0.6× 174 18.0k

Countries citing papers authored by Weiya Xia

Since Specialization
Citations

This map shows the geographic impact of Weiya Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiya Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiya Xia more than expected).

Fields of papers citing papers by Weiya Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiya Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiya Xia. The network helps show where Weiya Xia may publish in the future.

Co-authorship network of co-authors of Weiya Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Weiya Xia. A scholar is included among the top collaborators of Weiya Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiya Xia. Weiya Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Jung-Mao, et al.. (2025). MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists. Science. 390(6769). eadl4089–eadl4089. 1 indexed citations
2.
Sun, Xian Wen, Wei‐Jan Wang, Ri‐Yao Yang, et al.. (2023). Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity. International Journal of Biological Sciences. 19(14). 4644–4656. 8 indexed citations
3.
Zhou, Ruoji, An Xu, Donghui Wang, et al.. (2018). A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing. Stem Cell Research. 27. 131–135. 7 indexed citations
4.
Jiao, Shiping, Weiya Xia, Hirohito Yamaguchi, et al.. (2017). PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clinical Cancer Research. 23(14). 3711–3720. 768 indexed citations breakdown →
5.
Lim, Seung-Oe, Chia‐Wei Li, Weiya Xia, et al.. (2016). EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. Cancer Research. 76(5). 1284–1296. 203 indexed citations
6.
Khotskaya, Yekaterina B., Jia Shen, Mariano Ponz‐Sarvisé, et al.. (2014). S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer.. PubMed Central. 38 indexed citations
7.
Wang, Xiaoping, Hitomi Saso, Takayuki Iwamoto, et al.. (2013). TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase. Cancer Research. 73(21). 6516–6525. 65 indexed citations
8.
Li, Chia‐Wei, Weiya Xia, Longfei Huo, et al.. (2012). Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1. Cancer Research. 72(5). 1290–1300. 389 indexed citations
9.
Bu, Dawei, Venetia Sarode, Raheela Ashfaq, et al.. (2011). Tamoxifen Downregulates Ets Oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction. Cancer Prevention Research. 4(11). 1852–1862. 13 indexed citations
10.
Chen, Chun‐Te, Hirohito Yamaguchi, Hong-Jen Lee, et al.. (2011). Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase. Molecular Cancer Therapeutics. 10(8). 1327–1336. 21 indexed citations
11.
Cheng, Xiaoyun, Weiya Xia, Jer-Yen Yang, et al.. (2010). Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary Tumorigenesis. Cancer Research. 70(19). 7684–7689. 16 indexed citations
12.
Yang, Jer-Yen, Chun-Ju Chang, Weiya Xia, et al.. (2010). Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer. Cancer Research. 70(11). 4709–4718. 60 indexed citations
13.
Xie, Xiaoming, Jennifer L. Hsu, Min Gew Choi, et al.. (2009). A novel hTERT promoter–driven E1A therapeutic for ovarian cancer. Molecular Cancer Therapeutics. 8(8). 2375–2382. 30 indexed citations
14.
Ding, Qingqing, Longfei Huo, Jer-Yen Yang, et al.. (2008). Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer. Cancer Research. 68(15). 6109–6117. 163 indexed citations
15.
Wang, Xianhui, Mingzhe Zheng, Gang Liu, et al.. (2007). Kruppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion. Cancer Research. 67(15). 7184–7193. 155 indexed citations
16.
Hu, Mickey C.‐T., Dung‐Fang Lee, Weiya Xia, et al.. (2004). IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a. Cell. 117(2). 225–237. 742 indexed citations breakdown →
17.
Zhou, Binhua P., Mickey C.‐T. Hu, Stephanie A. Miller, et al.. (2000). HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway. Journal of Biological Chemistry. 275(11). 8027–8031. 322 indexed citations
18.
Xia, Weiya, et al.. (1999). Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.. PubMed. 5(12). 4164–74. 246 indexed citations
19.
Xia, Weiya, Lei Li, Nobutaka Kiyokawa, et al.. (1997). Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.. PubMed. 3(1). 3–9. 127 indexed citations
20.
Zhang, Yujiao, Dihua Yu, Weiya Xia, & Mien‐Chie Hung. (1995). HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.. PubMed. 10(10). 1947–54. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026